A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones
- PMID: 21266549
- DOI: 10.1530/EJE-10-1038
A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones
Abstract
Objective: Adverse effects of long-term cross-sex hormone administration to transsexuals are not well documented. We assessed mortality rates in transsexual subjects receiving long-term cross-sex hormones.
Design: A cohort study with a median follow-up of 18.5 years at a university gender clinic. Methods Mortality data and the standardized mortality rate were compared with the general population in 966 male-to-female (MtF) and 365 female-to-male (FtM) transsexuals, who started cross-sex hormones before July 1, 1997. Follow-up was at least 1 year. MtF transsexuals received treatment with different high-dose estrogen regimens and cyproterone acetate 100 mg/day. FtM transsexuals received parenteral/oral testosterone esters or testosterone gel. After surgical sex reassignment, hormonal treatment was continued with lower doses.
Results: In the MtF group, total mortality was 51% higher than in the general population, mainly from increased mortality rates due to suicide, acquired immunodeficiency syndrome, cardiovascular disease, drug abuse, and unknown cause. No increase was observed in total cancer mortality, but lung and hematological cancer mortality rates were elevated. Current, but not past ethinyl estradiol use was associated with an independent threefold increased risk of cardiovascular death. In FtM transsexuals, total mortality and cause-specific mortality were not significantly different from those of the general population.
Conclusions: The increased mortality in hormone-treated MtF transsexuals was mainly due to non-hormone-related causes, but ethinyl estradiol may increase the risk of cardiovascular death. In the FtM transsexuals, use of testosterone in doses used for hypogonadal men seemed safe.
Comment in
-
Long-term cross-sex hormone treatment is safe in transsexual subjects.Asian J Androl. 2012 Nov;14(6):813-4. doi: 10.1038/aja.2012.89. Epub 2012 Aug 27. Asian J Androl. 2012. PMID: 22922319 Free PMC article.
Similar articles
-
Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.J Clin Endocrinol Metab. 2008 Jan;93(1):19-25. doi: 10.1210/jc.2007-1809. Epub 2007 Nov 6. J Clin Endocrinol Metab. 2008. PMID: 17986639 Review.
-
Mortality and morbidity in transsexual subjects treated with cross-sex hormones.Clin Endocrinol (Oxf). 1997 Sep;47(3):337-42. doi: 10.1046/j.1365-2265.1997.2601068.x. Clin Endocrinol (Oxf). 1997. PMID: 9373456
-
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.J Clin Endocrinol Metab. 2003 Dec;88(12):5723-9. doi: 10.1210/jc.2003-030520. J Clin Endocrinol Metab. 2003. PMID: 14671159
-
Mortality and morbidity in transsexual patients with cross-gender hormone treatment.Metabolism. 1989 Sep;38(9):869-73. doi: 10.1016/0026-0495(89)90233-3. Metabolism. 1989. PMID: 2528051
-
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.Gynecol Endocrinol. 2018 Jun;34(6):456-459. doi: 10.1080/09513590.2017.1395839. Epub 2017 Nov 5. Gynecol Endocrinol. 2018. PMID: 29105524 Review.
Cited by
-
Use of hormones and risk of venous thromboembolism.Rev Bras Ginecol Obstet. 2024 Apr 2;46:e-FPS02. doi: 10.61622/rbgo/2024FPS02. eCollection 2024. Rev Bras Ginecol Obstet. 2024. PMID: 38765519 Free PMC article.
-
Estrogen's sex-specific effects on ischemic cell death and estrogen receptor mRNA expression in rat cortical organotypic explants.Aging Brain. 2024 Apr 16;5:100117. doi: 10.1016/j.nbas.2024.100117. eCollection 2024. Aging Brain. 2024. PMID: 38650743 Free PMC article.
-
Breast Cancer Screening Referral Patterns and Compliance in Transgender Male Patients.Transgend Health. 2024 Apr 3;9(2):136-142. doi: 10.1089/trgh.2022.0069. eCollection 2024 Apr. Transgend Health. 2024. PMID: 38585250
-
Genistein and sex hormone treatment alleviated hepatic fat accumulation and inflammation in orchidectomized rats with nonalcoholic steatohepatitis.Heliyon. 2024 Feb 8;10(4):e26055. doi: 10.1016/j.heliyon.2024.e26055. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38380011 Free PMC article.
-
All-cause and suicide mortalities among adolescents and young adults who contacted specialised gender identity services in Finland in 1996-2019: a register study.BMJ Ment Health. 2024 Feb 17;27(1):e300940. doi: 10.1136/bmjment-2023-300940. BMJ Ment Health. 2024. PMID: 38367979 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous